Ridgeline FIT sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.
$69.99
Thymosin Beta-4 (TB-4) is a biologically active peptide consisting of 43 amino acids. In animal models, TB-4 has been examined in experimental models for multiple biological pathways. It has been shown to observed modulation of angiogenesis, tissue remodeling, inflammatory pathways, and oxidative stress in laboratory models, particularly in the heart and central nervous system. TB-4 is studied for its involvement in cellular signaling and matrix remodeling in vitro, making it a focal point in research related to tissue healing and regeneration. A synthetic analogue of the naturally occurring thymosin beta-4, TB-500, shares the same 43 amino acid sequence. This synthetic peptide has garnered attention for its impact on actin protein, cell migration, and wound healing. In both animal models and in vitro studies, TB-500 has demonstrated its potential to improve blood vessel growth, accelerate wound healing, decrease inflammation, and enhance the production of the extracellular matrix. Ongoing research is exploring the experimental investigations in cardiovascular, neurological, and aging pathway models.
The chemical structure of Thymosin Beta-4 (TB-4) is a peptide composed of 43 amino acids. The sequence of TB-4 is as follows:
Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Thr-Tyr-Thr-Val-Pro-Val-Thr
The peptide is synthesized from the naturally occurring thymosin beta-4, which is found in mammalian cells. The synthetic analogue TB-500, with the mentioned sequence, is known for its therapeutic potential in promoting wound healing, reducing inflammation, and modulating various physiological processes related to tissue repair and regeneration.
Thymosin Beta-4 (TB-500) has shown promise in contributing to heart repair processes. Research indicates its potential to facilitate the regeneration of cardiac tissues, making it a subject of interest in studies focused on heart-related conditions and injuries.
TB-500 is recognized for its ability to promote tissue regeneration and accelerate wound healing. Studies suggest that the peptide plays a crucial role in the regulation of cellular functions, influencing the repair and remodeling of damaged tissues. This property makes it a potential candidate for therapeutic applications in conditions involving tissue injuries.
In addition to its role in tissue repair, TB-500 has been investigated for its potential in treating dry eye disorders. The peptide’s ability to modulate inflammatory responses and promote tissue regeneration may contribute to its efficacy in addressing ocular conditions associated with dry eyes.
TB-500 is known for its positive impact on flexibility and physical movement. This effect is likely associated with its ability to enhance tissue repair and reduce inflammation, contributing to improved joint and muscle function.
TB-500 exhibits anti-inflammatory properties, which can be attributed to its influence on immune responses and tissue repair processes. The peptide has been studied for its capacity to mitigate inflammation, suggesting potential applications in conditions characterized by excessive inflammatory reactions.
In conclusion, Thymosin Beta-4 (TB-500) showcases a multifaceted range of effects, from contributing to heart repair and tissue regeneration to addressing specific health concerns like dry eye disorders and promoting overall flexibility. Its diverse properties make it a subject of ongoing research for potential therapeutic applications.
Reviews
There are no reviews yet.